Along with a panel of experts, IMF Chief Scientific Officer Dr. Brian G.M. Durie will speak on advances in myeloma research from ASCO and EHA.
At the upcoming IMWG Conference Series, “Making Sense of Treatment,” leading myeloma experts will discuss the latest drug therapy news from the June 2024 American Society of Clinical Oncology (ASCO) Annual Conference, IMF IMWG Summit, and the European Hematology Association (EHA) Annual Conference.
IMF Chief Scientific Officer Dr. Brian G.M. Durie will moderate the discussion, with María-Victoria Mateos, MD, PhD (University of Salamanca—Salamanca, Spain) and Thomas Martin, MD (University of California San Francisco—San Francisco, CA) serving as panelists.
Dr. Durie will open the session by discussing the large number of myeloma abstracts from the ASCO and EHA annual conferences this year. He will then share highlights from the IMF IMWG Summit.
The panel and Dr. Durie will then focus on the following topics:
- MGUS and Smoldering Multiple Myeloma (SMM)
- Current Challenges in Multiple Myeloma
- Future Directions of Frontline Therapy
- Immune Therapies (CAR T-cell and Bispecifics) and Next Generation Approaches
- New Myeloma Drugs and Endpoints
- Working Committee Reports
Join us LIVE on June 20, 2024! You won’t want to miss this lively discussion. Be on the forefront of the latest myeloma research!
